Form 40-24B2 AFL CIO HOUSING INVESTME
Tweet
Share
E-mail
Bay Area Key Market Website Table
|
ECONOMIC IMPACT OF HIT-FINANCED PROJECTS IN THE BAY AREA |
||||||
| In 2024 Dollars, Since Inception* | ||||||
| 23 | $651.8M | $1.1B | 11.2M | 3,681 | ||
| Projects | HIT Investment Amount | Total Development Cost | Hours
of Union Construction WorK |
Housing
Units Created or Preserved |
||
| $2.7B | 12.791 | $1.2B | $125.4M | 32% | ||
| Total Economic impact | Total
Jobs Across Industries |
Total Wages and Benefits | State
and Local Tax Revenue Generated |
Percent Affordable | ||
*Job and economic impact figures are estimates calculated using IMPLAN, an input-output model, based on HIT and HIT subsidiary Building America CDE, Inc. project data. Data is current as of December 31, 2025. Economic impact data is in 2024 dollars and all other figures are nominal. America CDE, Inc. is a portfolio investment of the HIT but, unless otherwise noted, its underlying projects are not held in the HIT’s portfolio.
Investors should consider the HIT’s investment objectives risks and expenses carefully before investing. Investors may view the HIT’s current prospectus, which contains more complete information, on its website at www.aflcio-hit.com and may obtain a copy from the HIT by calling the Marketing and Investor Relations Department at 202-331-8055. Investors should read the current prospectus carefully before investing.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Merck Presents One-Year Results from the Pivotal Phase 2b/3 BRUNELLO Study Evaluating Remigromig, a Tri-specific Agonist of the Wingless-related Integration Site (Wnt) Pathway, in Adults with Diabetic
- Genentech Presents New Phase III One-Year Data for Vamikibart in Uveitic Macular Edema (UME), a Serious Cause of Vision Loss
- Planning a Fall Road Trip With Oxygen? VARON Highlights Portable Oxygen Concentrators for Car Travel
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
